Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18207601rdf:typepubmed:Citationlld:pubmed
pubmed-article:18207601lifeskim:mentionsumls-concept:C0242428lld:lifeskim
pubmed-article:18207601lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:18207601lifeskim:mentionsumls-concept:C0935929lld:lifeskim
pubmed-article:18207601lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18207601lifeskim:mentionsumls-concept:C0033920lld:lifeskim
pubmed-article:18207601lifeskim:mentionsumls-concept:C0175659lld:lifeskim
pubmed-article:18207601lifeskim:mentionsumls-concept:C0349674lld:lifeskim
pubmed-article:18207601lifeskim:mentionsumls-concept:C0222045lld:lifeskim
pubmed-article:18207601pubmed:issue1lld:pubmed
pubmed-article:18207601pubmed:dateCreated2008-3-28lld:pubmed
pubmed-article:18207601pubmed:abstractTextIn this study we developed and evaluated the psychometric properties of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS), the first treatment satisfaction instrument specific to oral anti-diabetic agents (OADs). Three focus groups and three rounds of cognitive debriefing interviews with type 2 diabetes patients using OADs informed the development of the six-item SOADAS. The measurement properties of the SOADAS were evaluated in a US cross-sectional study. Patients completed the SOADAS, Treatment Satisfaction for Medication Questionnaire (TSQM), the Short Form-12 (SF-12) Health Survey and a demographic questionnaire. The first half of the recruited patient population was asked to return at 7 days follow-up to complete the SOADAS again. An exploratory factor analysis on the SOADAS yielded a one-factor solution, indicating that the SOADAS was uni-dimensional. The SOADAS had high internal consistency reliability (Cronbach's alpha=0.86) and acceptable test-retest reliability (ICC=0.79). It was correlated most highly with the TSQM (r=0.71, p<0.001) and least with the mental summary component score of the SF-12 (r=0.24, p=0.014). Mean SOADAS scores were approximately two points higher for participants with lower HbA(1c) values (<7%) versus those with higher values, and for participants without versus with selected symptoms (p<0.05). The findings from this study suggest that the SOADAS is a valid and reliable measure of patient satisfaction with oral anti-diabetic medications. This questionnaire may be useful for assessing outcomes in future clinical studies of oral anti-diabetic medications.lld:pubmed
pubmed-article:18207601pubmed:languageenglld:pubmed
pubmed-article:18207601pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18207601pubmed:citationSubsetIMlld:pubmed
pubmed-article:18207601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18207601pubmed:statusMEDLINElld:pubmed
pubmed-article:18207601pubmed:monthAprlld:pubmed
pubmed-article:18207601pubmed:issn1872-8227lld:pubmed
pubmed-article:18207601pubmed:authorpubmed-author:WildDianeDlld:pubmed
pubmed-article:18207601pubmed:authorpubmed-author:AndersonRoger...lld:pubmed
pubmed-article:18207601pubmed:authorpubmed-author:BeusterienKat...lld:pubmed
pubmed-article:18207601pubmed:authorpubmed-author:HorblyukRusla...lld:pubmed
pubmed-article:18207601pubmed:authorpubmed-author:ArondekarBhak...lld:pubmed
pubmed-article:18207601pubmed:authorpubmed-author:DonattiChrist...lld:pubmed
pubmed-article:18207601pubmed:authorpubmed-author:DibenedettiDa...lld:pubmed
pubmed-article:18207601pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18207601pubmed:volume80lld:pubmed
pubmed-article:18207601pubmed:ownerNLMlld:pubmed
pubmed-article:18207601pubmed:authorsCompleteYlld:pubmed
pubmed-article:18207601pubmed:pagination108-13lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:meshHeadingpubmed-meshheading:18207601...lld:pubmed
pubmed-article:18207601pubmed:year2008lld:pubmed
pubmed-article:18207601pubmed:articleTitlePsychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS).lld:pubmed
pubmed-article:18207601pubmed:affiliationOxford Outcomes, Oxford, UK. christina.donatti@oxfordoutcomes.comlld:pubmed
pubmed-article:18207601pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18207601pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18207601pubmed:publicationTypeValidation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18207601lld:pubmed